Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06333613 · ClinicalTrials.gov registry record · NA
Evaluation of Acuvue Oasys 1-Day Contact Lenses in New Wearers
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT06333613 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 36 participants.
The verdict
NCT06333613, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
This is a multi-site, bilateral, dispensing, non-randomized, uncontrolled, unmasked, single arm study to evaluate visual acuity in neophytes.
Interventions
- DEVICE ACUVUE OASYS® 1-DAY with HydraLuxe™ TECHNOLOGY (AO1D)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-03-26 |
| Est. Completion | 2024-05-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06333613
The ClinicalTrials.gov registry entry for NCT06333613 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ACUVUE OASYS® 1-DAY with HydraLuxe™ TECHNOLOGY (AO1D) is the first listed.
NCT06333613 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06333613 about?
NCT06333613 is a clinical study titled "Evaluation of Acuvue Oasys 1-Day Contact Lenses in New Wearers". This is a multi-site, bilateral, dispensing, non-randomized, uncontrolled, unmasked, single arm study to evaluate visual acuity in neophytes.
What is the current status of trial NCT06333613?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2024-03-26. Estimated completion is 2024-05-22.
What interventions are being tested in trial NCT06333613?
The interventions under investigation include: ACUVUE OASYS® 1-DAY with HydraLuxe™ TECHNOLOGY (AO1D) (DEVICE).
Who is sponsoring clinical trial NCT06333613?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.